Antagomir-1290 suppresses CD133⁺ cells in non-small cell lung cancer by targeting fyn-related Src family tyrosine kinase

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
Bo SunPingping Zuo

Abstract

Cancer stem-like cells (CSLCs) are involved in cancer initiation, development, and metastasis, and microRNAs (miRNAs) play pivotal roles in regulating CSLCs. miRNA-based therapeutic strategy associated with CSLCs might promise potential new therapeutic approaches. In the present study, we found that miR-1290 was increased in CD133(+) cells. Antagomir-1290 significantly suppressed tumor volume and weight initiated by CD133(+) cells in vivo. Furthermore, antagomir-1290 significantly inhibited the proliferation, clonogenicity, invasion, and migration of CD133(+) cells by targeting fyn-related Src family tyrosine kinase. These findings provide insights into the clinical prospect of miR-1290-based therapies for non-small cell lung cancer.

References

Jun 19, 1993·International Journal of Cancer. Journal International Du Cancer·W G CanceE T Liu
Nov 2, 2001·Nature·T ReyaI L Weissman
Feb 6, 2003·International Journal of Cancer. Journal International Du Cancer·Tanya MeyerWilliam G Cance
May 20, 2003·Nature Biotechnology·Aimee L JacksonPeter S Linsley
Nov 19, 2004·Nature·Sheila K SinghPeter B Dirks
Dec 3, 2005·Cancer Research·Anne T CollinsNorman J Maitland
Mar 3, 2006·Genes & Development·Marco Antonio Valencia-SanchezRoy Parker
Nov 24, 2006·Nature·Lucia Ricci-VitianiRuggero De Maria
Jan 6, 2007·International Journal of Cancer. Journal International Du Cancer·Shengyong YinJianren Gu
Mar 24, 2009·Current Opinion in Cell Biology·Lana Bozulic, Brian A Hemmings
May 26, 2009·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·Virginia TirinoGiuseppe Pirozzi
Jul 15, 2009·Cell Cycle·Eun-Kyoung YimShiaw-Yih Lin
Jul 14, 2012·Journal of Neuro-oncology·Xiuping ZhouRutong Yu
May 24, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Ang LiMichael Goggins
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Feb 7, 2014·BMC Cancer·Laura Maria PradellaDaniela Turchetti

❮ Previous
Next ❯

Citations

Apr 14, 2016·Cancer Metastasis Reviews·Raghuveera Kumar Goel, Kiven Erique Lukong
Aug 10, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H ImaokaM Kusunoki
Oct 26, 2016·Oncology Reports·Mateusz OlbromskiPiotr Dziegiel
Aug 16, 2019·International Journal of Molecular Sciences·Giuseppe MurdacaSebastiano Gangemi
May 19, 2019·Journal of Cellular Physiology·Marjan AghajaniBehzad Baradaran
Dec 12, 2018·Journal of Cellular Physiology·Zahra AsadzadehBehzad Baradaran
Sep 28, 2020·Nanomedicine : Nanotechnology, Biology, and Medicine·Meenu MehtaKamal Dua

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.